Self-sampling vs. reminder letter: effects on cervical cancer screening attendance and coverage

ISRCTN ISRCTN25346540
DOI https://doi.org/10.1186/ISRCTN25346540
Secondary identifying numbers N/A
Submission date
13/02/2010
Registration date
06/04/2010
Last edited
10/04/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ahti Anttila
Scientific

Pieni Roobertinkatu 9
Helsinki
00130
Finland

Study information

Study designRandomised open label controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeScreening
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet.
Scientific titleSelf-sampling vs. reminder letter: A randomised controlled trial to investigate the effects on cervical cancer screening attendance and coverage
Study objectivesSelf-sampling is more efficient than a written reminder letter in improving cervical cancer screening attendance and coverage among current non-attendees
Ethics approval(s)This study was approved by the Ethical Committee in Hospital District of Helsinki and Uusimaa in March 2008 (ref: 430/E9/07 HUS). It was also approved by the City of Espoo.
Health condition(s) or problem(s) studiedCervical cancer screening
InterventionAll non-participants after the primary cervical cancer screening invitation in the city of Espoo in years 2008 and 2009 received either a high-risk (hr) Human Papillomavirus (HPV) self-sampling test or a written reminder letter.
Both arms received an information letter on the study, information pamphlet on cervical cancer screening and HPV.
Participants in the self-sampling arm also received an informed consent sheet, Pantarhei Screener® self-sampling device (Panterhei Devices, Netherlands) and user instruction sheet on the use of the self-sampling test. Women to be screened were asked to use the sample within 2 weeks of its arrival and mail the sample within 24 hours of sample taking. Results of the screening test were promised within 2 months of the return.
Intervention typeOther
Primary outcome measureIncrease in attendance and coverage of cervical cancer screening
Secondary outcome measures1. Prevalence of hrPV-infections higher among those women that do not participate cervical cancer screening after the primary invitation.
2. Feasibility, usability and acceptance of self-testing among women
Overall study start date01/11/2008
Completion date31/05/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participantsapproximately 9000
Key inclusion criteriaWomen, ages 30-65, living in the city of Espoo who received an invitation to cervical cancer screening but did not take part.
Key exclusion criteriaAddress information for non-participants was updated from the Population Register Centre before the interventions were sent and women who had no address information available, were dead or living outside Espoo were excluded.
Date of first enrolment01/11/2008
Date of final enrolment31/05/2010

Locations

Countries of recruitment

  • Finland

Study participating centre

Pieni Roobertinkatu 9
Helsinki
00130
Finland

Sponsor information

Finnish Cancer Organisations (Finland)
Research organisation

Pieni Roobertinkatu 9
Helsinki
00130
Finland

Website http://www.cancer.fi
ROR logo "ROR" https://ror.org/05pgg4z49

Funders

Funder type

Research organisation

Finnish Cancer Organisations (Finland)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2011 Yes No